Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MORGAN STANLEY Major Shareholding Notification 2018

Nov 19, 2018

29766_rns_2018-11-19_8098dd1f-8111-4ee2-828a-803c0d8f46f2.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7727H

Morgan Stanley

19 November 2018

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Name of exempt principal trader: Morgan Stanley MUFG Securities Co., Ltd.
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree
Takeda Pharmaceutical Company Limited
(c) Name of the party to the offer with which exempt principal trader is connected: Shire plc
(d) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure
16 NOVEMBER 2018
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"
YES - Shire plc

2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                           

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 11,756,423 1.50 30,173,137 3.85
(2) Cash-settled derivatives: 29,703,809 3.79 11,001,671 1.40
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 185,000 0.02 185,000 0.02
TOTAL: 41,645,232 5.31 41,359,808 5.27

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A

3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/sales Total   number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary PURCHASES 1,684,224 4,407.0000 JPY 4,285.0000 JPY
Ordinary SALES 1,833,248 4,407.0000 JPY 4,287.0000 JPY

(b)       Cash-settled derivative transactions

Class of relevant security Product description

            e.g. CFD
Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
Ordinary CFD LONG 1800 4301.1294 JPY
Ordinary CFD SHORT 4300 4334.6145 JPY
Ordinary CFD LONG 2500 4293.0000 JPY
Ordinary CFD SHORT 600 4300.1666 JPY
Ordinary CFD LONG 3000 4307.1453 JPY
Ordinary CFD LONG 13500 4403.4740 JPY
Ordinary CFD SHORT 13700 4351.6666 JPY
Ordinary CFD SHORT 14900 4334.6145 JPY
Ordinary CFD LONG 4300 4407.0000 JPY
Ordinary CFD SHORT 61735 4490.3742 JPY
Ordinary CFD LONG 322759 4364.1987 JPY
Ordinary CFD SHORT 12100 4311.9256 JPY
Ordinary CFD SHORT 100 4318.0000 JPY
Ordinary CFD LONG 100 4304.0000 JPY
Ordinary CFD SHORT 300 4293.0000 JPY
Ordinary CFD LONG 4400 4313.8688 JPY
Ordinary CFD SHORT 56700 4315.9151 JPY
Ordinary CFD SHORT 100 4318.0000 JPY
Ordinary CFD LONG 600 4303.3333 JPY
Ordinary CFD SHORT 2200 4294.0454 JPY
Ordinary CFD LONG 2000 4312.4580 JPY
Ordinary CFD LONG 6000 4314.3500 JPY
Ordinary CFD SHORT 30000 4320.3977 JPY
Ordinary CFD SHORT 100 4293.0000 JPY
Ordinary CFD SHORT 700 4320.0000 JPY
Ordinary CFD SHORT 21000 4301.5785 JPY
Ordinary CFD SHORT 3200 4313.3437 JPY
Ordinary CFD SHORT 100 4339.0000 JPY
Ordinary CFD SHORT 14500 4316.2724 JPY
Ordinary CFD LONG 13700 4307.5364 JPY
Ordinary CFD LONG 37200 4309.9086 JPY
Ordinary CFD SHORT 53700 4312.4487 JPY
Ordinary CFD SHORT 800 4302.6250 JPY
Ordinary CFD LONG 200 4334.0000 JPY
Ordinary CFD SHORT 22000 4303.0738 JPY
Ordinary CFD LONG 43000 4301.1294 JPY
Ordinary CFD SHORT 22300 4351.6666 JPY
Ordinary CFD LONG 6800 4299.4294 JPY

(c)       Stock-settled derivative transactions (including options)                

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description             e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type    e.g. American, European etc. Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description

e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
###### Date of disclosure: 19 NOVEMBER 2018
###### Contact name: Craig Horsley
###### Telephone number: +44(141) 245 7736

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected].  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

4.   KEY INFORMATION

Identity of person whose open positions are being disclosed: Morgan Stanley MUFG Securities Co., Ltd.
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Takeda Pharmaceutical Company Limited

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security Product Description e.g call option Written or Purchased Number of Securities to which option or derivative relates Exercise Price Per Unit (USD) Type Expiry Date
Ordinary PUT PURCHASED 125,000 4507.0000 JPY European 13/12/2019
Ordinary CALL PURCHASED 125,000 4507.0000 JPY European 13/12/2019
Ordinary PUT PURCHASED 60,000 4596.0000 JPY European 14/06/2019
Ordinary CALL PURCHASED 60,000 4596.0000 JPY European 14/06/2019

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to contracts for differences ("CFDs") or spread bets.

The currency of all prices and other monetary amounts should be stated.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FEOEAFFNFESPFFF